Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161343 · ClinicalTrials.gov registry record · Phase 2
Maintaining HIV Prevention Gains in Female Adolescents
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 640
- Enrollment target
NCT00161343: Completed Phase 2 study, sponsored by University of Rochester.
NCT00161343 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 640 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (381% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00161343, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 640 participants
- Enrollment target
Study Summary
In this study, an intervention is tested that is designed to reduced risky sexual behaviors in adolescent females. Study design: * randomized, controlled study * participants: 640 girls aged 15-19 years old * length of follow-up: 1 year after the intervention is completed Study hypothesis: The experimental condition will significantly reduce risky sexual behaviors in adolescent females as measured by: * lower incidence of STI's at 6 and 12 months, as compared to baseline * decreased incidence of risky sexual behaviors * increased knowledge of the level of risk of certain behaviors * increased knowledge of safer sexual behaviors that can prevention HIV infection * increased motivation to reduce sexual risk * increased behavioral skills to reduce risk of HIV infection
Interventions
- BEHAVIORAL Health Improvement Project for Teens on HIV Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
What the finished NCT00161343 record still lists
NCT00161343 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (381% higher).
The record links to 0 conditions, and to 1 intervention - of which Health Improvement Project for Teens on HIV Prevention is the first listed.
NCT00161343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00161343 about?
NCT00161343 is a clinical study titled "Maintaining HIV Prevention Gains in Female Adolescents". In this study, an intervention is tested that is designed to reduced risky sexual behaviors in adolescent females. Study design: * randomized, controlled study * participants: 640 girls aged 15-19 years old * length of follow-up: 1 year after the intervention is completed Study hypothesis: The exp...
What is the current status of trial NCT00161343?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 640 participants. The study started on 2004-12. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00161343?
The interventions under investigation include: Health Improvement Project for Teens on HIV Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00161343?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00161343's enrollment target sits among peer trials
640 51st of 2000 higher than 1,950 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia